CClinicalTrials.gg
Status unknownNCT00771732Updated Oct 13, 2008

Using Light Therapy to Treat Toe Nail Fungus

A Phase 2 interventional study of light therapy and light therapy in Onychomycosis, sponsored by Nomir Medical Technologies. Status unknown at 1 site in United States. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2008-10-13.

Sponsored by Nomir Medical Technologies · Phase 2, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Oct 2008), so the status shown — last known as Recruiting — may be out of date.
Phase
Phase 2
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
All
01

Study summary

To see if four sessions of light therapy successfully treats nail fungus.

Read the detailed description

This study is a one year study which includes four treatment sessions of light therapy looking for clinical and mycological improvement.

02

Conditions studied

  • Onychomycosis

Browse trials for

Keywords

  • toe nail fungus
03

In context

Onychomycosis

147 studies on the registry are indexed under Onychomycosis; 13 are open to participants now.

This study's planned enrollment of 40 is below the median of 56 across 134 interventional studies indexed under Onychomycosis.

Browse Onychomycosis studies →

Lead sponsor

Nomir Medical Technologies is the lead sponsor of 3 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • toe nail fungus, not infolving lunula
  • between ages 18-70 years old

Exclusion criteria

Exclusion Criteria:

  • not on systemic anti-fungal medications
05

Study design

Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Single group
Masking
Single (Participant)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    1

    Light therapy

    Device: light therapy

  • Sham comparator
    2

    6 minute "session" given with machine "off"

    Device: light therapy

Interventions

  • Devicelight therapy

    6 minute light therapy

    Also known as: laser threapy

  • Devicelight therapy

    combination of wavelengths

    Also known as: No therapy/machine is "off"

06

What researchers measure

Primary outcomes

  1. clinical improvement

    Time frame: six months

Secondary outcomes

  1. mycological negative

    Time frame: 6 months

07

Study locations

1 of 1 sites recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 13, 2008, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00771732
Lead sponsor
Nomir Medical Technologies
First posted
Oct 13, 2008
Start date
May 2008
Primary completion
Aug 2009 (estimated)
Completion
Dec 2009 (estimated)
Last update
Oct 13, 2008

Study contacts

Mary E Oster
Contact
m.oster@nomirmedical.com
781-893-1000
Alan Robbins, M.D.
Contact
alanhrobbins@comcast.com
781-893-1000
Alan Robbins, M.D.
study chair · Nomir Medical Technologies

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Oct 2008. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion